4Chen ZM, Pan HC, Chen YP et al. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomised placebo Ⅰ controlled trial. Lancet, 2005, 366 (9497): 1622-1632.
5Yang Y, Tang Y, Ruan Y, et al. Comparison of metoprolol with low, middle and high doses of carvedilol in prevention of postinfarction left ventricular remodeling in rats. Jpn Heart J, 2003,44 ( 6 ) : 979-988.
6Dickerson LM, Carek PJ. Are all beta lblockers equally effective in reducing mortality after acute myocardial infarction (AMI). J Fam Pract, 2001,50(8) :652.
7Nisar UR, Rahman, Yuen K, et al. Drug I polymer mixed coating : a new approach for controlling drug release rates in pellets. Pharm Dev Technol,2006,11 ( 1 ) :71-77.
8WyseDG, WaldoAL, Dimarco JP, et al .A comparison of rate control and rhythm control in patients with atrial fibrillation [ J ] .NEnglM ed, 2002, 347 ( 23 ): 1825-1833.
9Demircam C, Cikkriklar HI, Engindeniz Z, et al.Comparison ofthe effectiveness of intravenous diltiazem and metoprololl in the management of rapid ventricular rate in atrial fibrillation [J].Emerg Med J , 2005, 22( 6 ):. 411-414.
10Dia VC, Weir ST, Ellenbagen KA.Phamacokinetic and pharmacodynanics of intravenous dihiazem in patients with atrial fibrillation or atrial flutter [J ]. Circulation , 1992 , 86: 1421- 1428.
